These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 7695330)

  • 1. Antimalarial action of hydroxamate-based iron chelators and potentiation of desferrioxamine action by reversed siderophores.
    Golenser J; Tsafack A; Amichai Y; Libman J; Shanzer A; Cabantchik ZI
    Antimicrob Agents Chemother; 1995 Jan; 39(1):61-5. PubMed ID: 7695330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mode of action of iron(III) chelators as antimalarials. III. Overadditive effects in the combined action of hydroxamate-based agents on in vitro growth of Plasmodium falciparum.
    Tsafack A; Golenser J; Libman J; Shanzer A; Cabantchik ZI
    Mol Pharmacol; 1995 Feb; 47(2):403-9. PubMed ID: 7870051
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mode of action of iron (III) chelators as antimalarials: II. Evidence for differential effects on parasite iron-dependent nucleic acid synthesis.
    Lytton SD; Mester B; Libman J; Shanzer A; Cabantchik ZI
    Blood; 1994 Aug; 84(3):910-5. PubMed ID: 8043872
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The combined effect of iron chelators and classical antimalarials on the in-vitro growth of Plasmodium falciparum.
    van Zyl RL; Havlik I; Monteagudo FS
    J Antimicrob Chemother; 1992 Sep; 30(3):273-8. PubMed ID: 1452491
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mode of action of iron (III) chelators as antimalarials. IV. Potentiation of desferal action by benzoyl and isonicotinoyl hydrazone derivatives.
    Tsafack A; Loyevsky M; Ponka P; Cabantchik ZI
    J Lab Clin Med; 1996 Jun; 127(6):574-82. PubMed ID: 8648262
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Iron chelators: mode of action as antimalarials.
    Cabantchik ZI; Glickstein H; Golenser J; Loyevsky M; Tsafack A
    Acta Haematol; 1996; 95(1):70-7. PubMed ID: 8604590
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical Determinants of antimalarial activity of reversed siderophores.
    Tsafack A; Libman J; Shanzer A; Cabantchik ZI
    Antimicrob Agents Chemother; 1996 Sep; 40(9):2160-6. PubMed ID: 8878599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of hydroxypyridinone iron chelators in combination with antimalarial drugs on the in vitro growth of Plasmodium falciparum.
    Pattanapanyasat K; Kotipun K; Yongvanitchit K; Hider RC; Kyle DE; Heppner DG; Walsh DS
    Southeast Asian J Trop Med Public Health; 2001 Mar; 32(1):64-9. PubMed ID: 11485097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antimalarial properties of orally active iron chelators.
    Heppner DG; Hallaway PE; Kontoghiorghes GJ; Eaton JW
    Blood; 1988 Jul; 72(1):358-61. PubMed ID: 3291984
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Flow cytometric assessment of hydroxypyridinone iron chelators on in vitro growth of drug-resistant malaria.
    Pattanapanyasat K; Thaithong S; Kyle DE; Udomsangpetch R; Yongvanitchit K; Hider RC; Webster HK
    Cytometry; 1997 Jan; 27(1):84-91. PubMed ID: 9000589
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reversed siderophores act as antimalarial agents.
    Shanzer A; Libman J; Lytton SD; Glickstein H; Cabantchik ZI
    Proc Natl Acad Sci U S A; 1991 Aug; 88(15):6585-9. PubMed ID: 1862083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mode of action of iron (III) chelators as antimalarials: I. Membrane permeation properties and cytotoxic activity.
    Lytton SD; Mester B; Dayan I; Glickstein H; Libman J; Shanzer A; Cabantchik ZI
    Blood; 1993 Jan; 81(1):214-21. PubMed ID: 8417790
    [TBL] [Abstract][Full Text] [Related]  

  • 13. In vitro antimalarial effect of daphnetin relating to its iron-chelating activity.
    Mu LY; Wang QM; Ni YC
    Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi; 2002; 20(2):83-5. PubMed ID: 12567565
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antimalarial effect of iron chelators.
    Gordeuk VR; Loyevsky M
    Adv Exp Med Biol; 2002; 509():251-72. PubMed ID: 12572998
    [No Abstract]   [Full Text] [Related]  

  • 15. Iron chelators as antimalarial agents: in vitro activity of dicatecholate against Plasmodium falciparum.
    Pradines B; Rolain JM; Ramiandrasoa F; Fusai T; Mosnier J; Rogier C; Daries W; Baret E; Kunesch G; Le Bras J; Parzy D
    J Antimicrob Chemother; 2002 Aug; 50(2):177-87. PubMed ID: 12161397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Aminothiol multidentate chelators as antimalarials.
    Loyevsky M; John C; Zaloujnyi I; Gordeuk V
    Biochem Pharmacol; 1997 Aug; 54(4):451-8. PubMed ID: 9313771
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stage-dependent effect of deferoxamine on growth of Plasmodium falciparum in vitro.
    Whitehead S; Peto TE
    Blood; 1990 Sep; 76(6):1250-5. PubMed ID: 2205310
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malaria pigment and extracellular iron. Possible target for iron chelating agents.
    van Zyl RL; Havlik I; Hempelmann E; MacPhail AP; McNamara L
    Biochem Pharmacol; 1993 Apr; 45(7):1431-6. PubMed ID: 8471067
    [TBL] [Abstract][Full Text] [Related]  

  • 19. In vitro activity of iron-binding compounds against Senegalese isolates of Plasmodium falciparum.
    Pradines B; Tall A; Ramiandrasoa F; Spiegel A; Sokhna C; Fusai T; Mosnier J; Daries W; Trape JF; Kunesch G; Parzy D; Rogier C
    J Antimicrob Chemother; 2006 Jun; 57(6):1093-9. PubMed ID: 16595639
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential cytotoxicity of iron chelators on malaria-infected cells versus mammalian cells.
    Glickstein H; Breuer W; Loyevsky M; Konijn AM; Shanzer A; Cabantchik ZI
    Blood; 1996 Jun; 87(11):4871-8. PubMed ID: 8639861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.